BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 37843752)

  • 1. Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure.
    Meng S; Yu Y; Yu S; Zhu S; Shi M; Xiang M; Ma H
    J Cardiovasc Transl Res; 2024 Feb; 17(1):36-55. PubMed ID: 37843752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic remodeling of substrate utilization during heart failure progression.
    Chen L; Song J; Hu S
    Heart Fail Rev; 2019 Jan; 24(1):143-154. PubMed ID: 29789980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure.
    Wen J; Chen C
    J Cardiovasc Transl Res; 2024 Feb; 17(1):56-70. PubMed ID: 37450209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Modulators in Heart Disease: Past, Present, and Future.
    Lopaschuk GD
    Can J Cardiol; 2017 Jul; 33(7):838-849. PubMed ID: 28279520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac metabolism in heart failure: implications beyond ATP production.
    Doenst T; Nguyen TD; Abel ED
    Circ Res; 2013 Aug; 113(6):709-24. PubMed ID: 23989714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketones and the Heart: Metabolic Principles and Therapeutic Implications.
    Matsuura TR; Puchalska P; Crawford PA; Kelly DP
    Circ Res; 2023 Mar; 132(7):882-898. PubMed ID: 36996176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure.
    Selvaraj S; Kelly DP; Margulies KB
    Circulation; 2020 Jun; 141(22):1800-1812. PubMed ID: 32479196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases.
    Actis Dato V; Lange S; Cho Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts.
    Birkenfeld AL; Jordan J; Dworak M; Merkel T; Burnstock G
    Pharmacol Ther; 2019 Feb; 194():132-144. PubMed ID: 30149104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Potential implications of ketone body metabolism changes and ketogenic therapy in the treatment of heart failure].
    Wang Q; Yan S; Kuang S; Zhou M; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jul; 35(7):769-772. PubMed ID: 37545460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of energy metabolism in failing heart and its regulation by SIRT3.
    Wang X; Huang Y; Zhang K; Chen F; Nie T; Zhao Y; He F; Ni J
    Heart Fail Rev; 2023 Jul; 28(4):977-992. PubMed ID: 36708431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Cardiac Uptake of Ketone Bodies and Free Fatty Acids in Human Heart Failure and Hypertrophic Left Ventricular Remodeling.
    Voros G; Ector J; Garweg C; Droogne W; Van Cleemput J; Peersman N; Vermeersch P; Janssens S
    Circ Heart Fail; 2018 Dec; 11(12):e004953. PubMed ID: 30562098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of energy metabolism by combination therapy attenuates cardiac metabolic remodeling in heart failure.
    Huang Y; Zhang K; Jiang M; Ni J; Chen J; Li L; Deng J; Zhu Y; Mao J; Gao X; Fan G
    Int J Biol Sci; 2020; 16(16):3133-3148. PubMed ID: 33162820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
    Scolletta S; Biagioli B
    Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?
    Yurista SR; Chen S; Welsh A; Tang WHW; Nguyen CT
    Curr Heart Fail Rep; 2022 Aug; 19(4):180-190. PubMed ID: 35567658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketone body metabolism in diabetic and non-diabetic heart failure.
    Qian N; Wang Y
    Heart Fail Rev; 2020 Sep; 25(5):817-822. PubMed ID: 31612363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction.
    Wang W; Zhang F; Xia Y; Zhao S; Yan W; Wang H; Lee Y; Li C; Zhang L; Lian K; Gao E; Cheng H; Tao L
    Am J Physiol Heart Circ Physiol; 2016 Nov; 311(5):H1160-H1169. PubMed ID: 27542406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.